SELLAS Life Sciences (SLS) Cash from Investing Activities (2010 - 2023)

SELLAS Life Sciences (SLS) reported Cash from Investing Activities of -$3.0 million for Q3 2023, down 124.68% quarter-over-quarter from $12.2 million in Q4 2017.

SELLAS Life Sciences (SLS) Cash from Investing Activities (2010 - 2023) Analysis & Trends

SELLAS Life Sciences (SLS) has 8 years of Cash from Investing Activities data on file, last reported at -$3.0 million in Q3 2023.

  • Cash from Investing Activities for Q3 2023 came in at -$3.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$3.0 million (changed 0.0% YoY), and the FY2023 annual result was -$5.5 million, down 22.22% from the prior year.
  • Cash from Investing Activities slipped to -$3.0 million in Q3 2023 per SLS's latest filing, from $12.2 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$3.0 million in Q3 2023 and troughed at -$3.0 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 SELLAS Life Sciences 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 -3.00 Mn
Sep 30, 2023 -3.00 Mn
Dec 31, 2017 12.16 Mn
Dec 31, 2017 12.16 Mn
Sep 30, 2017 25,000.00
Sep 30, 2017 25,000.00
Jun 30, 2017 -7,000.00
Jun 30, 2017 -7,000.00
Mar 31, 2017 -18,000.00
Mar 31, 2017 -18,000.00
Dec 31, 2016 971,000.00
Dec 31, 2016 971,000.00
Sep 30, 2016 -1.05 Mn
Sep 30, 2016 -1.05 Mn
Mar 31, 2016 -6,000.00
Mar 31, 2016 -6,000.00
Dec 31, 2015 462,000.00
Dec 31, 2015 462,000.00
Sep 30, 2015 -248,000.00
Sep 30, 2015 -248,000.00